CLB
Core Laboratories NV
Core Laboratories NV historical holders
total: 9
Polen Capital Management Core Laboratories NV transactions over time
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2013 Q2 or earlier
- Held for:
- 2+ quarters
- Latest activity:
- 2013 Q4
Polen Capital Management has been an institutional investor in Core Laboratories NV (CLB) since at least 2013 Q2. According to 2026 Q1 report, Polen Capital Management doesn't hold any shares. In our earliest available record from 2013 Q2, Polen Capital Management held 3,306 shares of CLB. Since at least 2013 Q2, Polen Capital Management has made 2 more transactions in this position.
When did Polen Capital Management exit their CLB position?
Polen Capital Management no longer holds Core Laboratories NV (CLB). They sold off their entire position in 2013 Q4, closing out an investment that began in 2013 Q2.
Estimated cost basis*
- Weighted AVG buy price:
- $151.54
- Weighted AVG sell price:
- $169.36
CLB transactions history by Polen Capital Management
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.